XML 34 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Acquisitions and divestitures
9 Months Ended
Sep. 30, 2020
Business Combinations [Abstract]  
Acquisitions and divestitures
Acquisitions and divestitures
Routine acquisitions
During the nine months ended September 30, 2020, the Company acquired dialysis businesses consisting of eight dialysis centers located in the U.S. and 36 dialysis centers located outside the U.S. for a total of $112,597 in net cash, $6,917 in deferred purchase price obligations, and $21,021 in earn-out obligations and assumed liabilities. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company’s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.
The initial purchase price allocations for these transactions have been recorded at estimated fair values based on the best information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of pre-acquisition tax contingencies and filing of final tax returns. In addition, valuation of certain working capital items, fixed assets and intangibles are pending final audits and related valuation reports.
The following table summarizes the assets acquired and liabilities assumed in these transactions at their estimated acquisition date fair values: 
Current assets
$
17,606

Property and equipment
15,714

Intangible and other long-term assets
14,969

Goodwill
110,248

Deferred income taxes
1,513

Current liabilities
(17,786
)
Noncontrolling interests
(1,729
)

$
140,535


Amortizable intangible assets acquired during the nine months ended September 30, 2020 primarily represent non-compete agreements which had weighted-average estimated useful lives of approximately five years. The total estimated amount of goodwill deductible for tax purposes associated with these acquisitions was approximately $91,157.
Sale of RMS Lifeline
The Company also divested its vascular access business, RMS Lifeline, Inc., effective May 1, 2020 and recognized a loss on sale of approximately $16,252.
Contingent earn-out obligations
The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired companies a total of up to $37,467 if certain performance targets or quality margins are met primarily over the next one year to five years. As of September 30, 2020, the estimated fair value of these contingent earn-out obligations is $26,314, of which $7,400 is included in other current liabilities and the remaining $18,914 is included in other long-term liabilities in the Company’s consolidated balance sheet.
The following is a reconciliation of changes in contingent earn-out obligations for the three and nine month periods ended September 30, 2020:
 
Three months ended September 30, 2020
 
Nine months ended September 30, 2020
Beginning balance
$
24,057

 
$
24,586

Acquisitions
5,815

 
11,676

Foreign currency translation
(975
)
 
(6,358
)
Fair value remeasurements
(1,990
)
 
(2,630
)
Payments or other settlements
(593
)
 
(960
)
Ending balance
$
26,314

 
$
26,314